Engineered Regenerative and Adhesive Hydrogel for Concurrent Sealing and Healing of Enterocutaneous Fistulas

In addressing the intricate challenges of enterocutaneous fistula (ECF) treatment, such as internal bleeding, effluent leakage, inflammation, and infection, our research is dedicated to introducing a regenerative adhesive hydrogel that can seal and expedite the healing process. A double syringe setu...

Full description

Saved in:
Bibliographic Details
Published in:ACS applied materials & interfaces 2024-08, Vol.16 (31), p.40469-40482
Main Authors: Gangrade, Ankit, Zehtabi, Fatemeh, Ohe, Joo-Young, Kouchehbaghi, Negar Hosseinzadeh, Voskanian, Leon, Haghniaz, Reihaneh, Shepes, Matan, Rashad, Ahmad, Ermis, Menekse, Khademhosseini, Ali, Barros, Natan Roberto de
Format: Article
Language:English
Subjects:
Biological and Medical Applications of Materials and Interfaces
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In addressing the intricate challenges of enterocutaneous fistula (ECF) treatment, such as internal bleeding, effluent leakage, inflammation, and infection, our research is dedicated to introducing a regenerative adhesive hydrogel that can seal and expedite the healing process. A double syringe setup was utilized, with dopagelatin and platelet-rich plasma (PRP) in one syringe and Laponite and sodium periodate in another. The hydrogel begins to cross-link immediately after passing through a mixing tip and exhibits tissue adhesive properties. Results demonstrated that PRP deposits within the pores of the cross-linked hydrogel and releases sustainably, enhancing its regenerative capabilities. The addition of PRP further improved the mechanical properties and slowed down the degradation of the hydrogel. Furthermore, the hydrogel demonstrated cytocompatibility, hemostatic properties, and time-dependent macrophage M1 to M2 phase transition, suggesting the anti-inflammatory response of the material. In an in vitro bench test simulating high-pressure fistula conditions, the hydrogel effectively occluded pressures up to 300 mmHg. In conclusion, this innovative hydrogel holds promise for ECF treatment and diverse fistula cases, marking a significant advancement in its therapeutic approaches.
ISSN:1944-8244
1944-8252
1944-8252
DOI:10.1021/acsami.4c05154